Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the genetic toxicology testing market grown over the years?

In the recent past, the genetic toxicology testing market has experienced swift growth. The market size, which was valued at $1.63 billion in 2024, is predicted to rise to $1.8 billion in 2025, growing at a compound annual growth rate (CAGR) of 10.4%. Factors contributing to the growth during the historic period include ongoing public health crises, the rise in globalization, a shift towards personalized medicine, a surge in the demand for comprehensive testing solutions, and the growth in the number of drugs.

What Is the forecasted market size and growth rate for the genetic toxicology testing market?

Rapid expansion is anticipated in the genetic toxicology testing market in the coming years, with its value expected to swell to $2.64 billion by 2029 at a compound annual growth rate (CAGR) of 10.0%. Factors contributing to this projected growth include an increase in testing for new food products, growing awareness of potential risks, environmental and health concerns, heightened regulatory scrutiny, a surge in the use of in vitro testing methods, and the emergence of high-throughput screening platforms. Forecast trends comprise advanced precision medicine and toxicogenomic, thorough risk communication, improved genetic toxicology testing methodologies, progress in risk assessment methods, the merging of omics technologies, and strides in genomics and molecular biology.

Get your genetic toxicology testing market report here!

https://www.thebusinessresearchcompany.com/report/genetic-toxicology-testing-global-market-report

What are the major factors driving growth in the genetic toxicology testing market?

The genetic toxicology testing market’s growth is anticipated to be driven by the growing need for personalised medicine. This medical model enables tailored healthcare decisions, methods, interventions, and products based on the patient’s probable response or health risk. The market for personalized medicine has seen a positive surge due to genetic advancements, improved disease comprehension, the presence of diagnostics based on biomarkers, initiatives for value-based healthcare, and their integration into clinical practice and research. Genetic toxicology testing plays a pivotal role in personalised medicine by offering crucial data about genetic variability, vulnerability to genotoxic agents, and treatment response. For instance, 16 new personalized medicines for rare disease patients were approved by the FDA in 2023, a significant jump from only six in 2022, as per a report by the Personalized Medicine Coalition, a non-profit organization based in the US in February 2024. Hence, the escalating demand for personalised medicine is stimulating the growth of the genetic toxicology testing market.

What key areas define the segmentation of the global genetic toxicology testing Market?

The genetic toxicology testing market covered in this report is segmented –

1) By Type: In Vitro, In Vivo

2) By Product: Services, Reagents And Consumables, Assays

3) By Application: Healthcare Industry, Food Industry, Cosmetics Industry, Agriculture Industry, Other Applications

Subsegments:

1) By In Vitro: Ames Test, Micronucleus Assay, Comet Assay, Chromosomal Aberration Test, Cell Transformation Assay, Other In Vitro Methods

2) By In Vivo: Micronucleus Test (Rodent), Comet Assay (In Vivo), Bone Marrow Chromosomal Aberration Test, Dominant Lethal Test (Rodent), Other In Vivo Methods

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15574&type=smp

What are the top market players propelling the growth of the genetic toxicology testing industry?

Major companies operating in the genetic toxicology testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, SGS SA, WuXi AppTec, Intertek Group plc, Charles River Laboratories International Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Fraunhofer ITEM, Jubilant Life Sciences Limited, Evotec SE, Inotiv Inc., Promega Corporation, Syngene International Limited, Nelson Laboratories LLC, Instem, Frontage Laboratories Inc., Creative Bioarray, Creative Biolabs Inc., Gentronix Limited, MB Research Laboratories

What are the key trends shaping the future of the genetic toxicology testing market?

Pioneering businesses within the genetic toxicology testing market are concentrating their efforts on the creation of ground-breaking drug screening systems such as phenotypic drug screening to enhance precision and efficiency in spotting possible genetic toxins. Phenotypic drug screening is a technique that tests compounds according to their capacity to trigger a specific cellular or physiological response within an entire organism or a pertinent cell system. For example, in August 2022, Creative Biogene, a US biotechnology firm, introduced zebrafish disease models to aid drug discovery and toxicology research. These models are engineered to simulate human genetic disorders in zebrafish, shedding light on disease pathogenesis, drug discovery, and toxicology. The zebrafish models from Creative Biogene provide an essential platform for evaluating drug toxicity, forecasting the safety of fresh compounds, and aiding the drug development pathway.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15574

What regions are dominating the genetic toxicology testing market growth?

North America was the largest region in the genetic toxicology testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genetic toxicology testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

ADME Toxicology Testing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/adme-toxicology-testing-global-market-report

Genetic Testing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report

Genetically Modified Crops Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/genetically-modified-crops-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: